Steven L. Zelenkofske

Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

Marc A. Pfeffer, John J.V. McMurray, Eric J. Velazquez et al. · New England Journal of Medicine · 2003 · 2.5K citations · Full text

Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction

Nagesh S. Anavekar, John J.V. McMurray, Eric J. Velazquez et al. · New England Journal of Medicine · 2004 · 1.9K citations · Full text

Pathogenesis of Sudden Unexpected Death in a Clinical Trial of Patients With Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both

Anne–Catherine Pouleur, Ebrahim Barkoudah, Hajime Uno et al. · Circulation · 2010 · 217 citations · Full text

Albuminuria response to very high-dose valsartan in type 2 diabetes mellitus

Norman K. Hollenberg, Hans‐Henrik Parving, Giancarlo Viberti et al. · Journal of Hypertension · 2007 · 145 citations

Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial

A. Michael Lincoff, Roxana Mehran, Thomas J. Povsic et al. · The Lancet · 2015 · 143 citations

Thrombosis, Percutaneous Coronary Intervention, Reg1 Anticoagulation System +11